Dagens Medicin A/S — Credit Rating and Financial Key Figures
CVR number: 20052678
Møntergade 19, 1116 København K
tel: 33769666
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 14 877.01 | 16 335.76 | 11 167.25 | 12 483.65 | 14 426.15 |
| Employee benefit expenses | -11 915.76 | -11 449.76 | -11 362.17 | -11 881.25 | -13 389.20 |
| Total depreciation | - 290.61 | - 266.40 | |||
| EBIT | 2 670.64 | 4 619.61 | - 194.92 | 602.40 | 1 036.95 |
| Other financial income | 167.59 | 0.32 | 11.40 | 145.50 | 208.90 |
| Other financial expenses | -56.12 | -75.58 | -43.39 | -14.37 | -24.50 |
| Pre-tax profit | 2 782.11 | 4 544.35 | - 226.91 | 733.52 | 1 221.34 |
| Income taxes | - 613.85 | -1 003.21 | 48.18 | - 166.63 | - 278.11 |
| Net earnings | 2 168.26 | 3 541.14 | - 178.73 | 566.89 | 943.23 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 266.40 | ||||
| Intangible assets total | 266.40 | ||||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current other receivables | 55.00 | 55.00 | 55.00 | 55.00 | 55.00 |
| Long term receivables total | 55.00 | 55.00 | 55.00 | 55.00 | 55.00 |
| Finished products/goods | 54.00 | 55.84 | |||
| Inventories total | 54.00 | 55.84 | |||
| Current trade debtors | 4 199.59 | 3 759.42 | 3 121.39 | 3 152.11 | 3 315.72 |
| Current amounts owed by group member comp. | 9 564.15 | 7 188.80 | 3 776.75 | 5 279.60 | 6 290.03 |
| Prepayments and accrued income | 111.34 | 290.29 | 147.54 | 230.75 | 88.28 |
| Current other receivables | 16.61 | 762.96 | 46.11 | ||
| Current deferred tax assets | 68.76 | 116.94 | 7.15 | 70.90 | |
| Short term receivables total | 13 891.69 | 11 307.27 | 7 162.62 | 9 432.57 | 9 811.05 |
| Cash and bank deposits | 10.73 | 10.94 | 37.74 | 33.66 | |
| Cash and cash equivalents | 10.73 | 10.94 | 37.74 | 33.66 | |
| Balance sheet total (assets) | 14 277.81 | 11 429.05 | 7 217.62 | 9 525.31 | 9 899.71 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 2 000.00 | 2 000.00 | 2 000.00 | 2 000.00 | 2 000.00 |
| Shares repurchased | 4 000.00 | 4 000.00 | |||
| Other reserves | 207.80 | ||||
| Retained earnings | -1 816.94 | -3 440.88 | 100.26 | -78.47 | 488.41 |
| Profit of the financial year | 2 168.26 | 3 541.14 | - 178.73 | 566.89 | 943.23 |
| Shareholders equity total | 6 559.12 | 6 100.26 | 1 921.53 | 2 488.41 | 3 431.64 |
| Provisions | 22.00 | ||||
| Non-current liabilities total | |||||
| Advances received | 440.68 | 169.48 | 7.00 | 475.00 | 125.00 |
| Current trade creditors | 784.21 | 502.41 | 424.75 | 1 220.12 | 430.35 |
| Current owed to group member | 129.57 | 289.63 | |||
| Short-term deferred tax liabilities | 179.57 | 443.92 | |||
| Other non-interest bearing current liabilities | 4 275.76 | 2 428.45 | 2 150.91 | 2 264.22 | 2 464.59 |
| Accruals and deferred income | 2 066.46 | 1 938.83 | 2 713.42 | 2 897.98 | 3 004.20 |
| Current liabilities total | 7 696.69 | 5 328.79 | 5 296.09 | 7 036.89 | 6 468.06 |
| Balance sheet total (liabilities) | 14 277.81 | 11 429.05 | 7 217.62 | 9 525.31 | 9 899.71 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.